Patients with pulmonary arterial hypertension (PAH), 38% were found to have pulmonary artery aneurysms (PAA), and both the PAH time course and connective tissue disease were shown to modify the risk for PAA development, according to study results published in The American Journal of Cardiology.
All news from Pulmonary Medicine
Treating patients who have idiopathic pulmonary fibrosis (IPF) with pirfenidone (Esbriet, Genentech) increases their 3-year survival rates and confers a 30% survival benefit compared with patients who have not been treated with antifibrotic agents, according to a retrospective observational intention-to-treat study.
Idiopathic pulmonary fibrosis (IPF) is a chronic disease with a high symptom burden and poor survival that influences patients' health-related quality of life (HRQOL). We aimed to evaluate IPF patients' symptoms and HRQOL in a well-documented clinical cohort during their last two years of life.
Lung transplant recipients have a five-fold higher risk of lung cancer compared to the general population, and while these cancers are diagnosed earlier, survival is worse, a new analysis of data from the Transplant Cancer Match (TCM) Study shows.
Adults hospitalized for pneumonia who received influenza vaccination during their stay were less likely to seroconvert if they had diabetes, bacterial detection, baseline seropositive titers for influenza B, or influenza vaccination in the previous season, according to study results published in the journal Influenza and Other Respiratory Viruses .
Inhalation of hypertonic saline improves lung function and growth in infants with cystic fibrosis (CF), according to the results of the PRESIS randomized controlled trial.
The European Medicines Agency's (EMA's) Committee for Medicinal Products for Human Use (CHMP) recommended marketing authorization for a hybrid tobramycin nebulizer solution ( Tobramycin PARI, PARI Pharma GmbH) for chronic pulmonary infection from Pseudomonas aeruginosa in patients aged 6 years and older with cystic fibrosis More information on the marketing authorization is available on the EMA website.
Use of inferior vena cava (IVC) does not appear to have a mortality benefit – and may confer to mortality risk – in older adults with pulmonary embolism (PE), a study has shown.
The results of the study, conducted by Behnood Bikdeli and colleagues, were published online in a research letter in JAMA Internal Medicine . The findings contradict those from previous analyses of administrative databases in which there was limited adjustment for potential confounders, they write
Researchers have identified a key mechanism of lung inflammation induced by silica exposure, which leads to silicosis, an incurable disease. Their study in mice and patients shows that this inflammation can be prevented by extracellular DNA degradation, suggesting a new therapeutic target.
Rates of hospital readmission for acute exacerbations of chronic obstructive pulmonary disease (COPD) can be reduced significantly with a "discharge care bundle" that costs next to nothing to implement, new research shows.
Patients with combined pre and postcapillary pulmonary hypertension (CpcPH) secondary to left-sided heart failure (HF) who underwent a pulmonary artery denervation (PADN) procedure had significant improvements in hemodynamic and clinical outcomes at 6 months, compared with patients who underwent a sham procedure, in the PADN-5 trial.
A number of patients who suffer from asthma are bringing their condition under control, increasing their lung function and decreasing the frequency of asthma attacks—all without going to the doctor's office. The patients involved in a URI College of Nursing professor's study are benefitting from an emerging trend among nurses to increase patient care by treating them through technology.